Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder Article Text Original article Effective? Engaging? Secure? Applying

Eszopiclone for insomnia. BACKGROUND: Insomnia is a major public health issue affecting between 6% to 10% of the adult population in Western countries. Eszopiclone is a hypnotic drug belonging to a newer group of hypnotic agents, known as new generation hypnotics, which was marketed as being just as effective as benzodiazepines for this condition, while being safer and having a lower risk for abuse and dependence. It is the aim of the review to integrate evidence from randomised controlled (...) trials and to draw conclusions on eszopiclone's efficacy and safety profile, while taking methodological features and bias risks into consideration. OBJECTIVES: To assess the efficacy and safety of eszopiclone for the treatment of insomnia compared to placebo or active control. SEARCH METHODS: We searched the Cochrane Central Register of Controlled trials (CENTRAL), MEDLINE, Embase, PsycINFO, PSYNDEX and registry databases (WHO trials portal, ClinicalTrials.gov) with results incorporated from

Melatonin (Slenyto) - insomnia (difficulty sleeping) in children and adolescents (2 to 18 years old) Slenyto | European Medicines Agency Search Search Menu Slenyto melatonin Table of contents Authorised This medicine is authorised for use in the European Union. Overview Slenyto is a medicine for treating insomnia (difficulty sleeping) in children and adolescents (2 to 18 years old) who have: autism spectrum disorder (ASD), a range of conditions that affects the patient’s social interactions (...) of the brain and helping to bring about sleep. Its levels in the blood normally increase after the onset of darkness and peak in the middle of the night. Patients with developmental conditions may produce less melatonin, leading to the development of insomnia. Slenyto increases levels of melatonin in the blood, helping them to sleep. Because Slenyto releases melatonin slowly over a few hours, it mimics the natural production of melatonin in the body. What benefits of Slenyto have been shown in studies

Insomnia Top results for insomnia - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for insomnia The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care 29886347 2018 06 12 1873-491X 85 2018 May 24 International journal of nursing studies Int J Nurs Stud Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care. 126-135 S0020-7489(18)30114-7 10.1016/j.ijnurstu.2018.05.002 People typically seek primary health care for daytime symptoms and impairments (...) they experience in association with their insomnia. However, few studies address the question of whether insomnia treatment can improve such symptomatology. To investigate whether a nurse-led group treatment program, based on the techniques of cognitive behavioral therapy for insomnia (CBT-I), improved daytime symptomatology in primary care patients with insomnia. Fatigue (Fatigue Severity Scale [FSS]; main outcome), mood (General Health Questionnaire and Montgomery-Asberg Depression Rating Scale), health

Antidepressants for insomnia in adults. BACKGROUND: Insomnia disorder is a subjective condition of unsatisfactory sleep (e.g. sleep onset, maintenance, early waking, impairment of daytime functioning). Insomnia disorder impairs quality of life and is associated with an increased risk of physical and mental health problems including anxiety, depression, drug and alcohol abuse, and increased health service use. hypnotic medications (e.g. benzodiazepines and 'Z' drugs) are licensed for sleep (...) promotion, but can induce tolerance and dependence, although many people remain on long-term treatment. Antidepressant use for insomnia is widespread, but none is licensed for insomnia and the evidence for their efficacy is unclear. This use of unlicensed medications may be driven by concern over longer-term use of hypnotics and the limited availability of psychological treatments. OBJECTIVES: To assess the effectiveness, safety and tolerability of antidepressants for insomnia in adults. SEARCH METHODS

Insomnia Insomnia - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Insomnia Last reviewed: August 2018 Last updated: April 2018 Summary One of the most common complaints reported in primary care. Unmanaged insomnia can cost over US $100 billion each year due to accidents and poor work productivity. Associated with anxiety, depression, and physical complaints. Diagnosis is made primarily by patient interview. Sleep (...) diaries, actigraphy, and polysomnography may assist in confirming diagnosis. Identification of the correct aetiology is essential, as interventions differ and may be harmful in some cases if the diagnosis is incorrect. Education regarding sleep hygiene techniques is useful to prevent chronic insomnia. The significant morbidity of insomnia indicates that it is a condition that warrants treatment. Definition As per the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), American

Treatments for Insomnia: A Review of Patient and Experiences and Perspectives Treatments for Insomnia: A Review of Patient and Experiences and Perspectives | CADTH.ca Find the information you need Treatments for Insomnia: A Review of Patient and Experiences and Perspectives Treatments for Insomnia: A Review of Patient and Experiences and Perspectives Published on: September 27, 2017 Project Number: RD0039-000 Product Line: Research Type: Drug Report Type: Peer-reviewed summary with critical (...) appraisal Result type: Report Question What are patient, caregiver, or family member experiences with and perspectives of treatment and management of insomnia? Key Message Only patient perceptions were available for review, there were no relevant data on caregiver or family member experiences. Patients’ perceptions of and engagements with pharmacotherapy tend to vary in relation to nightly levels of fatigue, daytime responsibilities and social normalization of medical sleeping aids. While the duration

Trajectories of change and long-term outcomes in a randomised controlled trial of internet-based insomnia treatment to prevent depression 28959453 2018 11 13 2056-4724 3 5 2017 Sep BJPsych open BJPsych Open Trajectories of change and long-term outcomes in a randomised controlled trial of internet-based insomnia treatment to prevent depression. 228-235 10.1192/bjpo.bp.117.005231 Insomnia treatment using an internet-based cognitive-behavioural therapy for insomnia (CBT-I) program reduces (...) program. Adults ( N =1149) with clinical insomnia and subclinical depression symptoms were recruited online from the Australian community. Depression, anxiety and insomnia decreased significantly by week 4 of the intervention period and remained significantly lower relative to control for >18 months (between-group Cohen's d =0.63, 0.47, 0.55, respectively, at 18 months). Effects on suicidal ideation were only short term. Two depression trajectories were identified using growth mixture models

Management of Insomnia Disorder in Adults: Current State of the Evidence

Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial 28489508 2017 05 10 2017 05 10 1527-7755 2017 May 10 Journal of clinical oncology : official journal of the American Society of Clinical Oncology J. Clin. Oncol. Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority (...) Trial. JCO2016710285 10.1200/JCO.2016.71.0285 Purpose Cognitive behavioral therapy for insomnia (CBT-I) and Tai Chi Chih (TCC), a movement meditation, improve insomnia symptoms. Here, we evaluated whether TCC is noninferior to CBT-I for the treatment of insomnia in survivors of breast cancer. Patients and Methods This was a randomized, partially blinded, noninferiority trial that involved survivors of breast cancer with insomnia who were recruited from the Los Angeles community from April 2008

Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical (...) Effectiveness and Guidelines Published on: June 26, 2017 Project Number: RB1113-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? What are the evidence-based guidelines regarding the use of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? Key Message One non-randomized study was identified regarding

Current Practice Analysis: Interventions for Insomnia Disorder Current Practice Analysis: Interventions for Insomnia Disorder | CADTH.ca CADTH Document Viewer Current Practice Analysis: Interventions for Insomnia Disorder Table of Contents Search this document Current Practice Analysis: Interventions for Insomnia Disorder June 2017 Introduction CADTH studied the use of interventions to treat insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current (...) practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings are based on a targeted literature review as well as on the results of qualitative research from surveys of primary care practitioners. This report presents a summary of findings. Issue Insomnia disorder is a common complaint in the primary care setting. 1 The most common symptoms of insomnia are difficulty in initiating

Current Practice Analysis: Interventions for Insomnia Disorder Current Practice Analysis: Interventions for Insomnia Disorder | CADTH.ca CADTH Document Viewer Current Practice Analysis: Interventions for Insomnia Disorder Table of Contents Search this document Current Practice Analysis: Interventions for Insomnia Disorder June 2017 Introduction CADTH studied the use of interventions to treat insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current (...) practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings are based on a targeted literature review as well as on the results of qualitative research from surveys of primary care practitioners. This report presents a summary of findings. Issue Insomnia disorder is a common complaint in the primary care setting. 1 The most common symptoms of insomnia are difficulty in initiating

Appropriate Use of Interventions for Adults With Insomnia Disorder Appropriate Use of Interventions for Adults With Insomnia Disorder | CADTH.ca Find the information you need Appropriate Use of Interventions for Adults With Insomnia Disorder Appropriate Use of Interventions for Adults With Insomnia Disorder Published on: February 23, 2017 Project Number: OP0527 Product Line: Result type: Report Projects listed as “in progress” are at various stages and points of completion. These products have (...) different processes and timelines; therefore, the timing of posting of the final reports varies. The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. Insomnia is a sleep disorder affecting approximately 13% of the Canadian population. People with insomnia often have difficulty falling asleep or difficulty remaining asleep. They may also wake

Insomnia. Effective management of insomnia begins with recognition and adequate assessment. Family doctors and other health care providers such as practice nurses and psychologists should routinely enquire about sleep habits as a component of overall health assessment. Identification and treatment of primary psychiatric disorders, medical conditions, circadian disorders, or specific physiological sleep disorders--eg, sleep apnoea and periodic limb movement disorder--are essential steps (...) in management of insomnia. Conditioned aspects of insomnia can be primary (psychophysiological insomnia) or may complicate sleep disturbance owing to other causes. Approved hypnotic drugs have clearly been shown to improve subjective and objective sleep measures in various short-term situations. Despite widespread use of standard hypnotics and sedating antidepressants for chronic insomnia, their role for this indication still remains to be further defined by research evidence. Non-pharmacological treatments

Randomised controlled trial: Cognitive?behavioural therapy for insomnia is effective, safe and highly deployable Cognitive–behavioural therapy for insomnia is effective, safe and highly deployable | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cognitive–behavioural therapy for insomnia is effective, safe and highly deployable Article Text Care of the older person Randomised controlled trial Cognitive–behavioural therapy for insomnia is effective, safe and highly deployable Michael V Vitiello Statistics from Altmetric.com Commentary on: Alessi C , Martin JL

Cognitive behavioural therapy for chronic insomnia RACGP - Cognitive behavioural therapy for chronic insomnia Username Password Password security changes or call 1800 284 789 Search the RACGP website Your browser has 'Cookies' disabled, alert boxes will continue to appear without this feature. / / / / / Cognitive behavioural therapy for chronic insomnia HANDI Making non-drug interventions easier to find and use Cognitive behavioural therapy for chronic insomnia Chronic insomnia is the third (...) most common psychological reason for GP consultations – most patients prefer not to take medication to overcome this problem Intervention Cognitive behavioural therapy for insomnia (CBT-i) including the following components: cognitive therapy, stimulus control, sleep restriction, sleep hygiene and relaxation. CBT-i may be delivered face-to-face, digitally or using a combination of both. Indication Chronic insomnia, defined as difficulty either getting to sleep or staying asleep for at least 3

Brief behavioural therapy for insomnia in adults RACGP - Brief behavioural therapy: insomnia in adults Username Password Password security changes or call 1800 284 789 Search the RACGP website Your browser has 'Cookies' disabled, alert boxes will continue to appear without this feature. / / / / / Brief behavioural therapy: insomnia in adults HANDI Making non-drug interventions easier to find and use Brief behavioural therapy: insomnia in adults Physical health problems are present in about one (...) -third of patients with insomnia. Intervention The provision of education about sleep hygiene and stimulus control strategies, and tailored advice about restricting the time spent in bed to change behaviours. The rationale is that by modifying waking behaviours, the physiological systems that regulate sleep (ie homeostatic and circadian drives) can be modified. Indication Chronic primary insomnia in adults. Primary insomnia is defined as repeated difficulty with sleep initiation, duration

Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline JCSM - Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline Search article archive here ADVERTISEMENT Current Issue: Volume: 14 Number: 04 Issue Navigator Volume 13 No. 02 .155-157 Michael J. Sateia, MD 1 ; William C. Sherrill, MD 2 (...) without the written permission of the AASM. Further, purchase does not permit the posting of article text on an online forum or website. E-mail Share Slides Please login to download PDF Subscribers can download and print full articles from current and past issues of the JCSM Not a subscriber? and receive a subscription to JCSM with your membership Special Articles http://dx.doi.org/10.5664/jcsm.6470 Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American